US health services deals insights: Year-end 2017

Deal activity seen in 2017 likely to continue

The Health Services sector continued to exhibit strong signs of deal activity during 2017 and has now eclipsed 200+ transactions for 13 consecutive quarters. We expect a continuation in this Health Services deal activity in 2018 based on a variety of trends and factors highlighted in the report.


Megadeals a major highlight in a period of regulatory uncertainty

In a year of regulatory uncertainty, 2017 was an active year for US Health Services deals. Although deal volume decreased slightly year-over-year, deal value increased significantly. There were five megadeals altogether, including two private equity transactions in the CRO space.

In 2017, the number of deals decreased by 2.5% to 967, but deal value increased 145.8% to $175.2 billion. Deal volume was greatest in Q1 (270 deals), and deal value was greatest in Q4 ($99.2 billion).

Contact us

Thaddeus Kresho
US Health Services Deals Leader
Tel: +1 (678) 419 4151

Nick Donkar
Partner, PwC’s Deals Practice
Tel: +1 (213) 217 3791

Follow us